HnRNP-F promotes the proliferation of bladder cancer cells mediated by PI3K/AKT/FOXO1

por Li, Fei, Xie, Weiwei, Fang, Yunze, Xie, Kunfeng, Liu, Wendong, Hou, Lina, Tan, Wanlong
Publicado 2021

The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials

por Li, Fei, Wang, Yu, Xie, Kunfeng, Fang, Yunze, Du, Yuejun, Hou, Lina, Tan, Wanlong
Publicado 2021

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer

por Yao, Zhihao, Zhang, Henghui, Zhang, Xuejun, Zhang, Zhiyong, Jie, Jirong, Xie, Kunfeng, Li, Fei, Tan, Wanlong
Publicado 2022

FGFBP1 as a potential biomarker predicting bacillus Calmette–Guérin response in bladder cancer

por Li, Fei, Zhang, Henghui, Wang, Yu, Yao, Zhihao, Xie, Kunfeng, Mo, Qixin, Fan, Qin, Hou, Lina, Deng, Fan, Tan, Wanlong
Publicado 2022

Synergistic ferroptosis‐starvation therapy for bladder cancer based on hyaluronic acid modified metal–organic frameworks

por Wang, Yu, Xie, Kunfeng, Chen, Wei, Fang, Yunze, Mo, Qixin, Zhang, Henghui, Zhao, Xinlei, Li, Dongqing, Tan, Wanlong, Zhao, Peng, Li, Fei
Publicado 2023